Wion
/World
/China's Sinovac vaccine has general efficacy of 50.4% in Brazil trials

China's Sinovac vaccine has general efficacy of 50.4% in Brazil trials

Edited By WION Video Desk

Published: Jan 13, 2021, 04:15 IST | Updated: Jan 13, 2021, 04:15 IST

China's Sinovac vaccine has general efficacy of 50.4% in Brazil trials

A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.38% in a late-stage trial in Brazil.

Trending Topics